[Federal Register Volume 77, Number 61 (Thursday, March 29, 2012)]
[Notices]
[Page 19024]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2012-7584]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications/contract proposal and the 
discussions could disclose confidential trade secrets or commercial 
property such as patentable material, and personal information 
concerning individuals associated with the grant applications, the 
disclosure of which would constitute a clearly unwarranted invasion of 
personal privacy.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Topic 279 Phase II: Facilitating the Transfer of Statistical 
Methodology into Practice.
    Date: April 24, 2012
    Time: 12 p.m. to 5 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: National Institutes of Health, 6116 Executive Boulevard, 
Room 707, Rockville, MD 20852 (Telephone Conference Call).
    Contact Person: Lalita D. Palekar, Ph.D. Scientific Review 
Officer Special Review and Logistics Branch, Division of Extramural 
Activities, National Cancer Institute, 6116 Executive Boulevard, 
Room 7141, Bethesda, MD 20892, 301-496-7575, [email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel Career Development (K08).
    Date: May 15, 2012.
    Time: 8 a.m. to 6 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400 
Wisconsin Avenue, Bethesda, MD 20814.
    Contact Person: Robert Bird, Ph.D., Chief, Resources and 
Training Review Branch, Division of Extramural, Activities, National 
Cancer Institute, 6116 Executive Boulevard, Room 8113, Bethesda, MD 
20892-8328, 301-496-7978, [email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; NCI SPORE in Lymphoma, Leukemia, Brain, Esophageal and 
Gastrointestinal Cancers.
    Date: May 23-24, 2012.
    Time: 8 a.m. to 1 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Bethesda North Marriott Hotel & Conference Center, 5701 
Marinelli Road, Bethesda, MD 20852.
    Contact Person: Caron A. Lyman, Ph.D., Scientific Review 
Officer, National Cancer Institute, Division of Extramural 
Activities, Research Programs Review Branch, 6116 Executive Blvd., 
Room 8119, Bethesda, MD 20892-8328, 301-451-4761, 
[email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Validation and Advanced Development of Emerging Technologies 
for Cancer Research (R33).
    Date: June 14, 2012.
    Time: 8 a.m. to 6 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Westin Alexandria, 400 Courthouse Square, Alexandria, VA 
22314.
    Contact Person: Marvin L. Salin, Ph.D., Scientific Review 
Officer, Special Review and Logistics Branch, Division of Extramural 
Activities, National Cancer Institute, NIH, 6116 Executive 
Boulevard, Room 7073, Bethesda, MD 20892-8329, 301-496-0694, 
[email protected].

    Information is also available on the Institute's/Center's home 
page: http://deainfo.nci.nih.gov/advisory/sep/sep.htm, where an 
agenda and any additional information for the meeting will be posted 
when available.

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, 
Cancer Construction; 93.393, Cancer Cause and Prevention Research; 
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer 
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer 
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer 
Control, National Institutes of Health, HHS)

    Dated: March 23, 2012.
Jennifer S. Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2012-7584 Filed 3-28-12; 8:45 am]
BILLING CODE 4140-01-P